维升药业-B(02561) - 2024 - 年度业绩

Financial Results - Visen Pharmaceuticals reported preliminary financial results for the year ending December 31, 2024[2]. - The unaudited preliminary financial data is available in the prospectus appendix dated March 13, 2025[3]. Company Information - The company is listed under stock code 2561 on the Hong Kong Stock Exchange[2]. - The announcement was made by the Executive Director and CEO, Mr. Lu Anbang, on March 27, 2025[3]. - The board of directors includes both executive and non-executive members, ensuring diverse oversight[3].